Trial Information
Epidemiological Registry Describing Treatment Reality and Therapy Modalities of Patients With Lung Cancer (NSCLC, SCLC and Neuroendocrine Tumors) Requiring Therapy.
Inclusion Criteria:
- all patients suffering from Small Cell Lung Cancer (SCLC), Non Small Lung Cancer
(NSCLC) or neuroendocrine tumors receiving therapy
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Outcome Measure:
Documentation of actually used therapy forms in bronchial carcinoma requiring treatment
Outcome Time Frame:
3 years per patient
Safety Issue:
No
Principal Investigator
Hans-Werner Tessen, MD
Investigator Role:
Principal Investigator
Authority:
Germany: Ethics Commission
Study ID:
IOM TLK
NCT ID:
NCT01192919
Start Date:
January 2010
Completion Date:
September 2016
Related Keywords:
- Observational Study
- Registry
- bronchial carcinoma
- progression free survival
- registry
- therapy-reality
- observation
- therapy sequences
- NSCLC
- SCLC
- Germany
- Erlotinib
- Bevacizumab
- Pemetrexed
- Lung Neoplasms
- Neuroendocrine Tumors